back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2022-06-14 13:02 Tx date 2022-06-10 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
4 - Director of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
+1,000,000 vol |
1,000,000 | |
| Filed 2022-06-14 13:01 Tx date 2022-06-10 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$150,000
+1,000,000 vol $0.15 each |
1,716,500 | |
| Filed 2022-01-04 16:58 Tx date 2022-01-04 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
4 - Director of Issuer
Holder: Napperville Corp. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,030
+50,000 vol $0.2406 each |
1,405,000 | |
| Filed 2021-12-23 18:37 Tx date 2021-12-23 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
4 - Director of Issuer
Holder: Napperville Corp. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$32,250
+150,000 vol $0.215 each |
1,355,000 | |
| Filed 2021-06-04 13:20 Tx date 2021-05-28 |
$TAAL
Taal Distributed Information Technologies Inc. |
Naprawa, Chris
5 - Senior Officer of Issuer
Holder: Napperville Corp. (Indirect Ownership)
|
Common Shares
57 - Exercise of rights
|
$850,420
+200,000 vol $4.25 each |
205,000 | |
| Filed 2021-06-04 13:16 Tx date 2021-05-28 |
$TAAL
Taal Distributed Information Technologies Inc. |
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-850,420
-200,000 vol $4.25 each |
0 | |
| Filed 2021-06-04 13:16 Tx date 2021-05-28 |
$TAAL
Taal Distributed Information Technologies Inc. |
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
$850,420
+200,000 vol $4.25 each |
200,000 | |
| Filed 2021-06-04 13:15 Tx date 2020-10-01 |
$TAAL
Taal Distributed Information Technologies Inc. |
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-05-06 11:30 Tx date 2021-05-05 |
$TAAL
Taal Distributed Information Technologies Inc. |
Naprawa, Chris
5 - Senior Officer of Issuer
Holder: Napperville Corp. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$24,857
+5,000 vol $4.97 each |
5,000 | |
| Filed 2021-05-06 11:29 Tx date 2020-10-01 |
$TAAL
Taal Distributed Information Technologies Inc. |
Naprawa, Chris
5 - Senior Officer of Issuer
Holder: Napperville Corp. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-12-11 15:12 Tx date 2020-12-11 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
4 - Director of Issuer
Holder: Napperville Corp. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,740
+20,000 vol $0.387 each |
1,205,000 | |
| Filed 2020-12-04 13:57 Tx date 2020-12-04 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
4 - Director of Issuer
Holder: Napperville Corp. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$20,000
+50,000 vol $0.40 each |
1,185,000 | |
| Filed 2020-12-03 12:35 Tx date 2020-12-02 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
4 - Director of Issuer
Holder: Napperville Corp. (Indirect Ownership)
|
Warrants
10 - Acquisition or disposition in the public market
|
$7,815
+75,000 vol $0.1042 each |
75,000 | |
| Filed 2020-12-03 12:04 Tx date 2018-06-26 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
4 - Director of Issuer
Holder: Napperville Corp. (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-10-14 16:19 Tx date 2020-10-13 |
$TAAL
Taal Distributed Information Technologies Inc. |
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$537,000
+300,000 vol $1.79 each |
300,000 | |
| Filed 2020-10-14 16:17 Tx date 2020-10-01 |
$TAAL
Taal Distributed Information Technologies Inc. |
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-09-14 10:18 Tx date 2020-09-10 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+400,000 vol |
400,000 | |
| Filed 2020-09-14 10:10 Tx date 2018-06-26 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-09-04 16:39 Tx date 2020-09-04 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
4 - Director of Issuer
Holder: Napperville Corp. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$39,750
+75,000 vol $0.53 each |
1,135,000 | |
| Filed 2020-02-14 10:37 Tx date 2020-02-14 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$32,000
+50,000 vol $0.64 each |
716,500 | |
| Filed 2020-02-07 17:19 Tx date 2020-02-07 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$21,945
+28,500 vol $0.77 each |
666,500 | |
| Filed 2020-02-07 17:19 Tx date 2020-02-07 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$51,100
+70,000 vol $0.73 each |
638,000 | |
| Filed 2019-12-16 16:09 Tx date 2019-12-13 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
5 - Senior Officer of Issuer
Holder: Napperville Corp. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,650
+5,000 vol $0.93 each |
1,060,000 | |
| Filed 2019-12-16 16:08 Tx date 2019-12-11 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
5 - Senior Officer of Issuer
Holder: Napperville Corp. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,600
+5,000 vol $0.92 each |
1,055,000 | |
| Filed 2019-08-30 12:04 Tx date 2019-08-28 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
5 - Senior Officer of Issuer
Holder: Napperville Corp. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$15,600
+10,000 vol $1.56 each |
1,050,000 | |
| Filed 2019-08-30 12:04 Tx date 2019-08-28 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
5 - Senior Officer of Issuer
Holder: Napperville Corp. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,800
+10,000 vol $1.48 each |
1,040,000 | |
| Filed 2019-08-30 12:01 Tx date 2019-08-28 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
5 - Senior Officer of Issuer
Holder: Napperville Corp. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,200
+10,000 vol $1.42 each |
1,030,000 | |
| Filed 2019-06-20 15:31 Tx date 2019-06-19 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
5 - Senior Officer of Issuer
Holder: Napperville Corp. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$48,000
+20,000 vol $2.40 each |
1,020,000 | |
| Filed 2019-04-24 10:25 Tx date 2018-10-09 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$60,000
+50,000 vol $1.20 each |
548,000 | |
| Filed 2019-04-24 10:24 Tx date 2018-10-05 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$90,000
+75,000 vol $1.20 each |
498,000 | |
| Filed 2019-04-24 10:21 Tx date 2018-10-09 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
-50,000 vol |
0 | |
| Filed 2019-04-24 10:20 Tx date 2018-10-05 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
-75,000 vol |
50,000 | |
| Filed 2019-04-22 16:50 Tx date 2018-06-26 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
5 - Senior Officer of Issuer
Holder: Napperville Corp. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-02-28 Tx date 2019-02-25 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$220,000
+100,000 vol $2.20 each |
1,431,889 | |
| Filed 2018-12-07 Tx date 2018-12-05 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$18,600
+15,000 vol $1.24 each |
1,331,889 | |
| Filed 2018-12-07 Tx date 2018-12-05 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,150
+5,000 vol $1.23 each |
1,316,889 | |
| Filed 2018-11-05 Tx date 2018-09-07 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$90,720
+100,800 vol $0.90 each |
||
| Filed 2018-11-05 Tx date 2018-10-05 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
+90,000 vol |
||
| Filed 2018-11-05 Tx date 2018-10-02 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,280
-3,200 vol $1.65 each |
1,296,889 | |
| Filed 2018-11-05 Tx date 2018-10-05 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
+60,000 vol |
||
| Filed 2018-11-05 Tx date 2018-10-05 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
+90,000 vol |
||
| Filed 2018-11-05 Tx date 2018-10-02 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,656
-1,600 vol $1.66 each |
1,300,089 | |
| Filed 2018-11-05 Tx date 2018-09-12 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$800,000
+888,889 vol $0.90 each |
1,311,889 | |
| Filed 2018-11-05 Tx date 2018-09-07 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$90,720
+100,800 vol $0.90 each |
||
| Filed 2018-11-05 Tx date 2018-06-26 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-11-05 Tx date 2018-10-05 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
+50,000 vol |
50,000 | |
| Filed 2018-11-05 Tx date 2018-10-02 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$24,600
+15,000 vol $1.64 each |
1,311,889 | |
| Filed 2018-11-05 Tx date 2018-10-05 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
+60,000 vol |
||
| Filed 2018-11-05 Tx date 2018-10-02 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-16,728
-10,200 vol $1.64 each |
1,301,689 | |
| Filed 2018-11-05 Tx date 2018-10-05 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
+75,000 vol |
125,000 | |
| Filed 2018-11-05 Tx date 2018-09-07 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$100,800
+112,000 vol $0.90 each |
423,000 | |
| Filed 2018-09-05 Tx date 2018-06-26 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
200,000 | ||
| Filed 2018-07-23 Tx date 2018-06-26 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
281,000 | ||
| Filed 2018-07-23 Tx date 2018-07-17 |
$KHRN
Khiron Life Sciences Corp. |
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$32,481
+30,000 vol $1.08 each |
311,000 |